Respimat

Drug delivery device used for the treatment of respiratory conditions

Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety of their products, such as tiotropium and ipratropium/salbutamol. According to the manufacturer, the reusability of the inhaler reduces its carbon footprint by 71%.[1]

References

  1. ^ "First reusable, propellant-free inhaler launched to cut plastic waste". Pharmaceutical Journal. 17 September 2019. Retrieved 19 November 2019.

Sources

  • Home — Respimat International
  • v
  • t
  • e
Routes of administration, dosage forms
Oral
Digestive tract (enteral)
Solids

Liquids
Oral mucosa (buccal, sublabial, sublingual)
Solids
Liquids
Respiratory tract (inhalation)
Solids

0
0
Liquids
Gas
Ophthalmic,
otic, nasalUrogenitalRectal (enteral)Dermal (topical)

(into tissue/blood)
Skin (transdermal)
Organs
Central nervous system
Circulatory,
musculoskeletal
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e